Lupin and Avas launch NaMuscla in Italy
Avas will initially commercialise NaMuscla as a Class C (Tier 2), while Lupin negotiates with AIFA (Agenzia Italiana del Farmaco)…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.